|
GTX40045
|
GeneTex International Corporation
|
Mycobacterium tuberculosis [BDI578], Mouse Monoclonal Antibody
|
Mycobacterium tuberculosis
|
ELISA, WB
|
|
|
GTX40235
|
GeneTex International Corporation
|
Mycobacterium tuberculosis CFP10 (10kDa culture filtrate protein) [B391M], Mouse Monoclonal Antibody
|
Mycobacterium tuberculosis
|
ELISA, sELISA
|
|
|
GTX40241
|
GeneTex International Corporation
|
Mycobacterium tuberculosis CFP10 (10kDa culture filtrate protein) [B386M], Mouse Monoclonal Antibody
|
Mycobacterium tuberculosis
|
ELISA, sELISA
|
|
|
GTX40519
|
GeneTex International Corporation
|
Mycobacterium tuberculosis [BDI577], Mouse Monoclonal Antibody
|
Mycobacterium tuberculosis
|
ELISA, WB
|
|
|
GTX40962
|
GeneTex International Corporation
|
Mycobacterium tuberculosis (FITC), Rabbit Polyclonal Antibody
|
|
ICC/IF
|
|
|
GTX57459-pro
|
GeneTex International Corporation
|
Mycobacterium tuberculosis ESAT6 Protein
|
|
|
|
|
HY-100725-10mg
|
MedChemexpress LLC
|
BM212 [CAS 146204-42-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-100725-5mg
|
MedChemexpress LLC
|
BM212 [CAS 146204-42-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-101040-1mg
|
MedChemexpress LLC
|
Telacebec [CAS 1334719-95-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-101040-10mg
|
MedChemexpress LLC
|
Telacebec [CAS 1334719-95-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-101040-100mg
|
MedChemexpress LLC
|
Telacebec [CAS 1334719-95-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-101040-5mg
|
MedChemexpress LLC
|
Telacebec [CAS 1334719-95-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-101040-50mg
|
MedChemexpress LLC
|
Telacebec [CAS 1334719-95-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-101867-10mg
|
MedChemexpress LLC
|
AU1235 [CAS 1338780-86-1]
|
|
Cancer-programmed cell death
|
|
|
HY-101867-100mg
|
MedChemexpress LLC
|
AU1235 [CAS 1338780-86-1]
|
|
Cancer-programmed cell death
|
|
|
HY-101867-2mg
|
MedChemexpress LLC
|
AU1235 [CAS 1338780-86-1]
|
|
Cancer-programmed cell death
|
|
|
HY-101867-25mg
|
MedChemexpress LLC
|
AU1235 [CAS 1338780-86-1]
|
|
Cancer-programmed cell death
|
|
|
HY-101867-5mg
|
MedChemexpress LLC
|
AU1235 [CAS 1338780-86-1]
|
|
Cancer-programmed cell death
|
|
|
HY-101867-50mg
|
MedChemexpress LLC
|
AU1235 [CAS 1338780-86-1]
|
|
Cancer-programmed cell death
|
|
|
HY-10392-10mg
|
MedChemexpress LLC
|
Sutezolid [CAS 168828-58-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-10392-100mg
|
MedChemexpress LLC
|
Sutezolid [CAS 168828-58-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-10392-25mg
|
MedChemexpress LLC
|
Sutezolid [CAS 168828-58-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-10392-5mg
|
MedChemexpress LLC
|
Sutezolid [CAS 168828-58-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-10392-50mg
|
MedChemexpress LLC
|
Sutezolid [CAS 168828-58-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-105099-10mg
|
MedChemexpress LLC
|
Rifalazil [CAS 129791-92-0]
|
|
COVID-19-anti-virus
|
|
